期刊文献+

依折麦布辛伐他汀片溶出度的HPLC法测定 被引量:3

Determination of the Dissolution of Ezetimibe/Simvastatin Tablets by HPLC
原文传递
导出
摘要 建立了高效液相色谱法测定依折麦布辛伐他汀片的溶出度。采用Inertsil ODS-3 色谱柱,以25 mmol/L 磷酸二氢钠溶液( 用10%磷酸调至pH 4.0)- 乙腈(49 ∶ 51) 为流动相,检测波长231 nm。依折麦布和辛伐他汀在1.0 ~ 12.0 μg/ml和2.0 ~ 24.0 μg/ml 浓度范围内线性关系良好;平均回收率为100.8%和100.5%,RSD 为1.0%和1.2%。3 批样品20 min内依折麦布和辛伐他汀的溶出度分别为101.5%、100.2%、101.9%和92.5%、90.9%、91.5%。 An HPLC method was established for the determination of the dissolution of ezetimibe/simvastatin tablets. An ODS-3 column was used, with the mobile phase of 25 mmol/L sodium dihydrogen phosphate solution (adjusted to pH 4.0 with 10% phosphoric acid)-acetonitrile (49︰51), at the detection wavelength of 231 nm. The calibration curves for ezetimibe and simvastatin were linear in the ranges of 1.0 - 12.0 μg/ml and 2.0 - 24.0 μg/ml. Their average recoveries were 100.8% and 100.5%, with RSDs of 1.0% and 1.2%. The ezetimibe dissolution at 20 min of three batches of samples were 101.5%, 100.2% and 101.9%, while that of simvastatin were 92.5%, 90.9% and 91.5%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第12期1275-1277,共3页 Chinese Journal of Pharmaceuticals
关键词 依折麦布辛伐他汀片 高效液相色谱 溶出度 测定 ezetimibe/simvastatin tablet HPLC dissolution determination
  • 相关文献

参考文献7

二级参考文献95

  • 1苏静英.辛伐他汀治疗1个月内改善内皮功能.国外医学:心血管疾病分册,1998,25(2):118-118.
  • 2钟倩.辛伐他汀获美国许可用于减少首次中风的危险性.国外医药:合成药.生化药制剂分册,1998,19(5):313-313.
  • 3Knopp RH.Drug treatment of lipid disorders[J].N Engl J Med,1999,341(7):498-511.
  • 4Kastelein JJP,Akdim F,Stroes ESC,et al.Simvastatin with or without ezetimibe in familial hypercholesterolemia[J].N Engl J Med,2008,58:1431-1443.
  • 5Zhao XQ,Yuan C,Hatsukami TS,et al.Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI:a case-control study[J].Arterioscler Thromb Vasc Biol,2001,21:1623-1629.
  • 6American College of Cardiology.American College of Cardiology statement on ENHANCE trial[EB/OL].http//www.acc.org/enhance.htm.2008-01-15.
  • 7Knopp RH,Dujovne CA,le Beaut A,et al.Evaluation of the efficacy,safety,and tolerability of ezetimibe in primary hypercholesterolaemia:a pooled analysis from two controlled phase Ⅲ clinical studies[J].Int J Clin Pract,2003,57:363-368.
  • 8Miura S,Saku K.Beneficial effects of ezetimibe-based therapy in patients with dyslipidemia[J].J Cardiol,2008,52(1):1-6.
  • 9van der Graaf A,Cuffie-Jackson C,Vissers MN,et al.Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia[J].J Am Coll Cardiol,2008,52(17):1421-1429.
  • 10Ballantyne CM,Houri J,Notarbartolo A.Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia[J].Circulation,2003,107:2409-2415.

共引文献70

同被引文献27

  • 1李江,林莉.辛伐他汀、依折麦布联合应用治疗高脂血症的临床价值[J].兵团医学,2013(3):12-13. 被引量:1
  • 2白元,秦永文.新型降脂药——依折麦布的研究进展[J].药学服务与研究,2007,7(3):187-190. 被引量:15
  • 3Sama J R, Kalakuntla R R, Rao V N, et al. Simultaneous estimation of atorvastatin and ezetimibe in pharmaceutical formulations by RP- HPLC method[J]. Der Pharmacia Lettre, 2010,2( 1 ):427.
  • 4Kumar P. Stability indicating method development for simultaneous estimation of ezetimibe and atorvastatin in pharmaceutical formulationsbyRP-HPLC[J].Pharm Anal Acta,2012(Suppl7):S7.
  • 5Goel A, Baboota S, Sahui J K, et al. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe[J]. J Chromatogr Sci, 2013, 51(3):222.
  • 6Taupitz T, Dressman J B, Klein S. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin[J]. Eur J Pharm Biopharm, 2013,84( 1 ):208.
  • 7Srivalli K R, Mishra B. Improved aqueous solubility and antihyperc- holesterolemic activity of ezetimibe on formulating with hydrox- ypropyl-β-eyelodextrin and hydrophilic auxiliary substances [J]. AAPS Pharm Sci Teeh, 2015 ,[Epub ahead of print].
  • 8胡杏林.伯氨喹林的药理作用及治疗效果[J].中级医刊,1960(5):26-27.
  • 9徐志敏.大剂量伯氨喹对抗伯氨喹间日虐的疗效[J].国外医学寄生虫病分册,1995(1):33.
  • 10任道性.伯氨喹林和氯喹啉的药理作用[J].人民军医,1963,(6):16-17.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部